Cardiology meetings & conferences

1st Annual International Conference on Cardiology & Cardiovascular Medicine Research (CCMR 2013)

December 9-10, 2013 Singapore

The Annual International Conference on Cardiology & Cardiovascular Medicine Research (CCMR) aims to be a platform for researchers, cardiologists, cardiac surgeons, and educators all over the world to present, share and exchange new medicine studies, research results, research analysis, innovations and advances in dealing with heart disorders or cardiovascular disease. The theme tends to be broad to incorporate the overarching perspective within the field of Cardiology and Cardiovascular Medicine.

CCMR CONFERENCE SECRETARIAT
Global Science & Technology Forum (GSTF)
10 Anson Road, International Plaza,
Singapore 079903
DID : +65 6327 0166
Fax : +65 6327 0162

For General Enquiries info@cardioresearch-conf.org
 

Innovations in Cardiovascular Interventions (ICI Meeting 2013)

“Innovations in Cardiovascular Interventions (ICI) - From Idea to Reality" will be held on December 1-3, 2013 in Tel-Aviv, Israel

The upcoming meeting will focus on innovative technology and therapies in the cardiovascular area and related exciting disciplines and will cover all stages of the innovation process from the bench to the patient bedside.

This year we will continue to watch closely the dynamic and vibrant area of valvular interventions and the many innovations under investigation for treating cardiac valvular pathology using percutaneous techniques or combined surgical and interventional pathways.

This year we will continue to review the regulatory, ethical and financial aspects of new devices and continue the Mobile health track that was an exciting topic last year which will continue with a special flavour within the scientific program.

Who should attend: Clinical cardiologists, innovative scientists, biomedical engineers, financial investors seeking opportunities and members of cutting edge teams in major companies in this field, who want to be part of the future of interventional cardiology.

Contact Us

ICI Secretariat:
Dan Knassim Ltd.
60 Medinat Hayehudim st.
P.O.Box 4195
Herzliya 46766
Israel
Tel/fax: 972-3- 5767739
Email: secretariat@icimeeting.com

TCT 25

October 27-November 1, 2013 San Francisco, California

Transcatheter Cardiovascular Therapeutics (TCT) is the world's largest educational meeting specializing in interventional cardiovascular medicine. For more than 20 years, TCT has been the center of new cutting-edge educational content.

TCT showcases the latest advances in current therapies and clinical research and our long-standing commitment to life-saving innovation to translate into improved patient care.

ACC is the Official Co-Sponsor of TCT

TCT, the world's largest educational meeting specializing in interventional vascular medicine, is now partnered with the American College of Cardiology (ACC). TCT together with the ACC will offer invaluable opportunities for the medical community to discover the latest advances in the field, share clinical experiences, and exchange new ideas and information with colleagues from around the world

5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus

21-24 November, 2013 Bangkok, Thailand

Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.

Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often  necessary to reach  early and sustained achievement of individualized  glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.

The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.

List of Topics

•  Treatment Simplification and Compliance

•  FDCs as First Step Treatment

•  FDC in Secondary Prevention

•  FDCs of Antihypertensive and Antidiabetic Drugs

•  FDCs of Antihypertensive and Lipid Lowering Drugs

•  FDC in the Elderly and Very Elderly

•  Ambulatory BP in the Assessment of FDC Efficacy

•  Home BP in the Assessment of FDC Efficacy

•  Combinations with Thiazides. Chlortalidone vs HCTZ

•  ACE Inhibitors  and  Diuretics FDC

•  ACE Inhibitors  and  Calcium Channel Blockers FDC

•  ARBs  and Diuretics  FDC

•  ARBs  and Calcium Channel Blockers  FDC

•  Triple Drug Combinations

•  The Polypills

•  FDCs as Generic Drugs

•  Guidelines

•  FDCs in Different Countries

•  Regulatory Aspects

•  Cost Issues

Contact Us

Conference Organizers

Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel:  +41 (0)22 533 0948    
Fax: +41 (0)22 580 2953

General Enquiries

Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com  
Fax: +41 (0)22 580 2953

Third International Congress on Cardiac Problems in Pregnancy

February 20-23, 2014 Venice, Italy

The goals of “The Third International Congress on Cardiac Problems in Pregnancy” are to continue advancing the knowledge and expertise of health care professionals around the globe by exchange of information, development of collaborative research both basic and clinical, discuss, adopt and upgrade recent guidelines for the management of cardiovascular conditions during pregnancy and the post partal period. The program will include invited lectures, workshops as well as original oral and poster presentations which will cover a wide spectrum of topics in all disciplines related to pregnancy associated cardiovascular conditions.

Who Should Attend?

This Congress is intended for:

Cardiologists

Gynecologists

Obstetricians

Anesthesiologists

Internists

Hypertension specialists

Medical Imaging Technicians

ASNC2013--18th Annual Scientific Session of the American Society of Nuclear Cardiology

September 26-29, 2013 Chicago, Ilinois

ASE 2013--24th Annual American Society of Echocardiography Scientific Sessions

June 29 – July 2, 2013 Minneapolis, Minnesota

CARDIOTECHNIX 2013

September 19-21, 2013 Vilamoura, Algarve, Portugal

Technology has been essential for the advancement in cardiology diagnostic and treatment since the first accurate recording of the electrocardiogram and its development as a clinical tool in 1895, also the year of the discovery of X-rays by W.K.Röntgen, followed by ultrasound application for medical diagnosis by Dussik in 1941, and many other technologies. In the XXI century significant advances continue to be witnessed even more frequently and it seems evident that there is a very high potential of improving healthcare quality by combining medical knowledge in the area of cardiology with engineering technologies, especially those derived from communications, electronics and informatics.

This conference intends to be a meeting point of both academics and practitioners, in order to promote the exchange ideas and developed synergies.

Congress Areas

1 . Cardiovascular Imaging and Cardiography
2 . Computing and Telecommunications in Cardiology
3 . Surgical Technologies and Advanced Robotics

Secretariat

CARDIOTECHNIX Secretariat
Address: Av. D. Manuel I, 27A, 2º esq.
             2910-595 Setúbal - Portugal
Tel.: +351 265 100 033
Fax: +20 3014 9464
e-mail: cardiotechnix.secretariat@insticc.org
Web: http://www.Cardiotechnix.org

18th World Congress on Heart Disease

International Academy of Cardiology, 18th World Congress on Heart Disease, Annual Scientific Sessions 2013

July 26-29, 2013 Vancouver, BC, Canada

The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of Molecular and Cellular Cardiology, Genetics of Heart Disease, Cardiac Imaging, Coronary Artery Disease, Peripheral Arterial Disease, Interventional Cardiology, Lipoprotein Disorders, Hypertension, Metabolic Syndrome, Heart Failure, Valvular Heart Disease, Diseases of the Aorta, Cardiac Arrhythmias and Electrophysiology, Implantable Cardiac Pacemakers and Cardioverter-Defibrillators, Sudden Cardiac Death, Pediatric Cardiology, Congenital Heart Disease, Cardiac Surgery, Heart Transplantation, Mechanical Circulatory Support and Measurement of Outcome and Quality of Cardiovascular Care.

For further information:

International Academy of Cardiology
18th World Congress on Heart Disease
Annual Scientific Sessions 2013
PO Box 17659, Beverly Hills, CA 90209, USA
Tel: +1 310 657 8777; Fax: +1 310 659 4781
e-Mail: Klimedco@ucla.edu

Cardiac Biology - From Development to Regenerative Medicine

European Molecular Biology Laboratory Heidelberg, Germany

Friday 7 June - Monday 10 June 2013

Why You Should Attend

Regenerative medicine is a prime example of the interdisciplinary trend in contemporary biomedical research, incorporating developmental and stem cell biology, biomaterials and tissue engineering, gene and cell therapeutic approaches. The science underpinning recent advances in tissue repair has already provided significant clinical outcomes in many organ systems, yet the challenges facing regeneration of the cardiovascular system are particularly complex. The mature mammalian heart is particularly refractory to recovery after insult, mysteriously losing the robust cardiac regenerative capacity of the embryo, which is retained by other species into adulthood. This conference will cover recent discoveries in cardiac developmental biology, compare cardiac systems across the evolutionary spectrum, and explore the fundamental barriers to cardiac self-renewal in the clinical context. International specialists will share their latest work in this challenging field, focusing on the interface of basic and translational research.

Aims of event

This conference will cover recent discoveries in cardiac developmental biology, compare cardiac systems across the evolutionary spectrum, and explore the fundamental barriers to cardiac self-renewal in the clinical context. International specialists will share their latest work in this challenging field, focusing on the interface of basic and translational research.

Topics

Heart development and evolution, cardiovascular disease, heart regenerative strategies, therapeutic approaches

Who should attend

Developmental Biologists, Cardiac Biologists, Cardiologists, Cardiothoraric Surgeons, Pediatric Cardiologists